Publications

European journal of cancer (Oxford, England : 1990)

From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy.

15-05-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

15-05-2026

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.

14-05-2026

European radiology experimental

MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.

13-05-2026

Journal for immunotherapy of cancer

Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

13-05-2026

Cancer discovery

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

13-05-2026

Proceedings of the National Academy of Sciences of the United States of America

Acupuncture does not work and has no place in science-based medicine.

12-05-2026

Nature communications

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

12-05-2026

Scientific reports

Crowdsourcing enables robust cell annotation for breast cancer pathology.

11-05-2026

Genome medicine

The contribution of rare germline variants to the immune landscape of breast cancer.

09-05-2026

Cancers

Recruitment Strategies, Response Rates, and Non-Response Patterns in a Nationwide Registry-Based PRO Survey of Cancer Survivors and the General Population: The SURV-ICE Cohort.

08-05-2026

BMJ open

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.

07-05-2026

NPJ breast cancer

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

06-05-2026

Breast cancer research and treatment

Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?

05-05-2026

Journal of cancer survivorship : research and practice

Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma.

05-05-2026

Current oncology (Toronto, Ont.)

Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study.

05-05-2026

BMJ open

Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study.

04-05-2026

European journal of cancer (Oxford, England : 1990)

BRAF^V600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.

02-05-2026

European journal of cancer (Oxford, England : 1990)

The development of the European Toolkit for the self-assessment of quality of life across the cancer care continuum (EUonQoL-Kit).

02-05-2026

FEBS open bio

Optimizing photoactivation of PA-mCherry for optical pooled CRISPR screens.

01-05-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

01-05-2026

Annals of surgical oncology

ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.

01-05-2026

Trends in cancer

FGFR rearrangements: oncogenic drivers and therapeutic targets.

01-05-2026

Physics and imaging in radiation oncology

Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.

01-05-2026

The Lancet regional health. Europe

Advances in cell therapy for solid tumours: European perspective and future directions.

01-05-2026

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Health-related quality of life and functional outcomes of colon cancer patients in the Netherlands: A population-based study.

01-05-2026

International journal of radiation oncology, biology, physics

Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.

01-05-2026

Clinical and translational radiation oncology

ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer.

01-05-2026

Physics and imaging in radiation oncology

Clinical feasibility of fast adaptive four-dimensional cone-beam computed tomography for lung cancer radiotherapy.

01-05-2026

European urology

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

01-05-2026

Clinical pharmacokinetics

Exposure-Response Relationships of Antibody Drug Conjugates in Solid Tumours.

01-05-2026

Nature

Prospective evaluation of genomics-guided off-label treatment.

01-05-2026

Nature protocols

Inducible CRISPR-Cas9 screening platform to interrogate non-proliferative cellular states.

01-05-2026

Trends in immunology

Parental leave in immunology-2.

01-05-2026

European journal of radiology

Concurrent driver mutations induce distinct tumour morphologies on radiological imaging.

01-05-2026

British journal of cancer

Association between effectiveness of treatment with curative intent and outcomes of first-line systemic therapy in metachronous metastatic gastroesophageal adenocarcinoma.

01-05-2026

Histopathology

Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

01-05-2026

Molecular systems biology

Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms.

01-05-2026

The FEBS journal

Beyond the chaos: How architecture structures tumour biology.

01-05-2026

Medical image analysis

Incorporating global-local tissue changes to predict future breast cancer from longitudinal screening mammograms.

01-05-2026

Bone marrow transplantation

Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children.

01-05-2026

Molecular oncology

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD-L1 in melanoma.

01-05-2026

Journal of medical Internet research

Time-Dynamic AI Models to Predict Quality of Life in Patients With Breast Cancer: Development and Validation Study Using the EORTC BALANCE Cohort.

30-04-2026

European radiology

Radiomics-based outcome prediction for irinotecan-TACE in colorectal liver metastases: advanced analysis from the prospective CIREL trial.

29-04-2026

Nature communications

Mapping functional non-coding variation in individual human genomes through haplotyping, multiomics, and deep learning.

29-04-2026

Nature communications

Microbiota-derived metabolites as modulators of cancer immunotherapy response.

21-04-2026

NPJ breast cancer

Development and internal validation of mammography feature-based prognostic models for distant recurrence-free survival of invasive breast cancer in a screening cohort.

20-04-2026

Journal of medical genetics

Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study.

20-04-2026

Journal of the National Cancer Institute

Risk of autoimmune and rheumatic diseases in breast cancer patients with silicone breast implants.

19-04-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

Transcriptomic insights into lobular breast cancer biology and patient outcomes: analysis of the MINDACT clinical trial.

17-04-2026

From prediction to precision: Biomarker discovery and predictive modeling for personalized immune checkpoint blockade therapy.

PI3K Inhibition in Combination with Tamoxifen in Patients with Metastatic HR+/HER2- Breast Cancer: Clinical and Circulating Tumor DNA Results.

Simultaneous concurrent chemoradiation and SBRT in stage III NSCLC: Safety report of the phase I hybrid trial.

MRI radiomics predicting cribriform growth informs active surveillance decision in intermediate-risk prostate cancer.

Local immunotherapy in the neoadjuvant treatment of cancer: optimizing efficacy while limiting toxicity?

Mismatch Repair-Proficient Colorectal Cancer can evade Immune Surveillance Through an Intrinsic Suppressive Program.

Acupuncture does not work and has no place in science-based medicine.

E-cadherin inactivation shapes tumor microenvironment specificities in invasive lobular breast cancer.

Crowdsourcing enables robust cell annotation for breast cancer pathology.

The contribution of rare germline variants to the immune landscape of breast cancer.

Recruitment Strategies, Response Rates, and Non-Response Patterns in a Nationwide Registry-Based PRO Survey of Cancer Survivors and the General Population: The SURV-ICE Cohort.

Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trial.

Enabling DCIS subtyping: leveraging foundation models for robust grading and molecular biomarker scoring.

Long-term outcomes in triple-negative breast cancer after a pathologic complete response: does the type of neoadjuvant therapy matter?

Long-term cognitive function after treatment with immune checkpoint inhibition for melanoma.

Quality of Life and Healthcare Experiences of Patients with Anal Cancer: A Mixed-Methods Study.

Pre-diagnostic route reported by patients with sarcoma from the Netherlands, the UK, Australia and New Zealand: early detection challenges for general practitioners - an international observational cohort study.

BRAFV600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.

The development of the European Toolkit for the self-assessment of quality of life across the cancer care continuum (EUonQoL-Kit).

Optimizing photoactivation of PA-mCherry for optical pooled CRISPR screens.

plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis-Derived Variants in Liquid Biopsies from Patients with Solid Tumors.

ASO Visual Abstract: International Survey on Evidence for Index Lymph Node Surgery Following Neoadjuvant Systemic Therapy for Stage III Melanoma.

FGFR rearrangements: oncogenic drivers and therapeutic targets.

Estimation of accumulated dose to organs at risk in head and neck cancer patients treated with scheduled replanning and dose painting in the ARTFORCE trial.

Advances in cell therapy for solid tumours: European perspective and future directions.

Health-related quality of life and functional outcomes of colon cancer patients in the Netherlands: A population-based study.

Primary Endpoint Analysis of the Phase 2 DESTINATION-MRL Trial for Patients With Intermediate-Risk Prostate Cancer.

ESTRO consensus guidelines on GTV delineation and dose-escalation in rectal cancer.

Clinical feasibility of fast adaptive four-dimensional cone-beam computed tomography for lung cancer radiotherapy.

Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT Study.

Exposure-Response Relationships of Antibody Drug Conjugates in Solid Tumours.

Prospective evaluation of genomics-guided off-label treatment.

Inducible CRISPR-Cas9 screening platform to interrogate non-proliferative cellular states.

Parental leave in immunology-2.

Concurrent driver mutations induce distinct tumour morphologies on radiological imaging.

Association between effectiveness of treatment with curative intent and outcomes of first-line systemic therapy in metachronous metastatic gastroesophageal adenocarcinoma.

Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.

Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms.

Beyond the chaos: How architecture structures tumour biology.

Incorporating global-local tissue changes to predict future breast cancer from longitudinal screening mammograms.

Risk factors for alloimmune lung syndromes after allogeneic hematopoietic cell transplantation in children.

Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD-L1 in melanoma.

Time-Dynamic AI Models to Predict Quality of Life in Patients With Breast Cancer: Development and Validation Study Using the EORTC BALANCE Cohort.

Radiomics-based outcome prediction for irinotecan-TACE in colorectal liver metastases: advanced analysis from the prospective CIREL trial.

Mapping functional non-coding variation in individual human genomes through haplotyping, multiomics, and deep learning.

Microbiota-derived metabolites as modulators of cancer immunotherapy response.

Development and internal validation of mammography feature-based prognostic models for distant recurrence-free survival of invasive breast cancer in a screening cohort.

Later age of natural menopause among women with the pathogenic CHEK2 c.1100delC variant: a validation study.

Risk of autoimmune and rheumatic diseases in breast cancer patients with silicone breast implants.

Transcriptomic insights into lobular breast cancer biology and patient outcomes: analysis of the MINDACT clinical trial.

This site uses cookies

BRAF^V600E-mutated central nervous system tumors benefit from treatment with dabrafenib plus trametinib: Results from the Drug Rediscovery Protocol.